542910 VALENCIA

Valencia Nutrition Share Price

₹44.82 -2.34 (-4.96%)

16 Jan, 2025 12:44

SIP TrendupStart SIP in VALENCIA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -18.51%
  • Over 3 Month -24.1%
  • Over 6 Month + 21.46%
  • Over 1 Year -41.34%
SIP Lightning

Smart Investing Starts Here Start SIP with Valencia Nutrition for Steady Growth!

Invest Now

Valencia Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Valencia Nutrition Financials

Valencia Nutrition Technicals

EMA & SMA

Current Price
₹44.82
-2.34 (-4.96%)
pointer
  • stock-down_img
  • Bearish Moving Average 14
  • stock-up_img
  • Bullish Moving Average 2
  • 20 Day
  • ₹51.72
  • 50 Day
  • ₹49.27
  • 100 Day
  • ₹47.39
  • 200 Day
  • ₹41.08

Resistance and Support

46.38 Pivot Speed
  • R3 52.64
  • R2 51.07
  • R1 47.95
  • S1 43.26
  • S2 41.69
  • S3 38.57

What's your outlook on Valencia Nutrition?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Valencia Nutrition has an operating revenue of Rs. 2.97 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of -104% needs improvement, NULL The stock from a technical standpoint is trading below to its 50DMA and around 15% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 30% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 117 indicates it belongs to a poor industry group of Beverages-Non-Alcoholic and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Valencia Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Half Yearly Results
2024-05-30 Audited Results
2023-12-30 Others Rs.0.00 alia, to consider : 1. Draft Letter of Offer for the proposed rights issue for an aggregate amount up to Rs. 22,00,00,000 (Rupees Twenty Two Crores Only)
2023-12-12 Others Inter alia, to consider : 1. Reclassification of Ms. Deepthi Anand from 'Promoter/Promoter Group' to 'Public Category pursuant to Regulation 31A of SEBI Regulations, 2015. issue of equity shares of Rs. 10/- in the ratio of 15:10 @ premium of Rs. 16/-.
2023-11-20 Others Inter alia, to consider and approve the proposal for fund raising by the issue of permissible securities including a rights issue, preferential issue or through any other permissible mode issue of equity shares of Rs. 10/- in the ratio of 15:10 @ premium of Rs. 16/-.

Valencia Nutrition F&O

Valencia Nutrition Shareholding Pattern

64.87%
20.04%
15.09%

About Valencia Nutrition

  • NSE Symbol
  • VALENCIA
  • BSE Symbol
  • 542910
  • Managing Director
  • Mr. Manish Turakhia
  • ISIN
  • INE08RT01016

Similar Stocks to Valencia Nutrition

Valencia Nutrition FAQs

Valencia Nutrition share price is ₹44 As on 16 January, 2025 | 12:30

The Market Cap of Valencia Nutrition is ₹62.6 Cr As on 16 January, 2025 | 12:30

The P/E ratio of Valencia Nutrition is -45.2 As on 16 January, 2025 | 12:30

The PB ratio of Valencia Nutrition is 9.9 As on 16 January, 2025 | 12:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23